Mereo BioPharma Balance Sheet (2017-2026)

Reported Financials

Mereo BioPharma Quarterly Balance Sheet

Periods 24 quarters

Latest Jun 2026

Mereo BioPharma reported total assets of $34.71M and total liabilities of $6.06M for the quarter ended Jun 2026, down 44.6% year over year. This balance sheet covers 24 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Jun2020	Dec2020	Jun2021	Dec2021	Jun2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	69.95M	31.99M	152.40M	127.28M	92.71M	67.92M		53.12M		57.42M	48.70M	87.43M	80.52M	69.80M	62.50M	56.13M	48.70M	40.99M	30.10M	30.12M
Cash & Current Investments	69.95M	31.99M	152.40M	127.28M	92.71M	67.92M		53.12M		57.42M	48.70M	87.43M	80.52M	69.80M	62.50M	56.13M	48.70M	40.99M	30.10M	30.12M
Receivables - NetNet Receivables						0.92M		9.96M
Receivables - OtherOther Receivables		0.88M		1.39M		0.48M				1.95M
Receivables						1.40M		9.96M
Prepaid Assets						5.45M				5.16M	3.19M	4.49M	3.83M	2.18M	2.52M	2.55M	2.69M	2.53M	2.25M	1.60M
Current Assets	82.09M	40.52M	166.58M	134.07M	99.25M	74.91M		68.41M		63.76M	53.50M	93.94M	86.72M	74.76M	66.90M	61.42M	52.41M	45.02M	40.03M	33.40M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	13.82M	2.14M	3.31M	3.42M	2.56M	2.21M		1.97M		0.41M	0.36M	0.34M	0.32M	0.26M	0.25M	0.22M	0.17M	0.14M	0.09M	0.05M
Intangibles	39.24M	43.14M	30.72M	33.16M	29.26M	29.08M		31.34M		1.09M	0.97M	0.87M	0.80M	0.64M	0.55M	0.47M	0.64M	0.52M	0.38M	0.26M
Goodwill & Intangibles	39.24M	43.14M	30.72M	33.16M	29.26M	29.08M		31.34M		1.09M	0.97M	0.87M	0.80M	0.64M	0.55M	0.47M	0.64M	0.52M	0.38M	0.26M
Other Non-Current Assets										0.62M		0.48M	0.44M	0.38M	0.38M	0.40M	0.39M	0.40M	0.39M	0.39M
Non-Current Assets	53.06M					2.51M				2.74M	2.44M	2.19M	2.02M	1.63M	1.42M	1.21M	1.20M	0.90M	0.58M	1.31M
Assets	135.15M					77.41M				66.50M	55.94M	96.13M	88.75M	76.39M	68.32M	62.63M	53.60M	45.92M	40.61M	34.71M
Liabilities
Current Liabilities
Accounts Payables	6.76M	4.54M	3.03M	3.37M	3.42M	3.71M		2.41M		2.35M	2.46M	2.70M	1.75M	2.44M	2.92M	1.14M	0.88M	1.33M	3.23M	1.12M
Notes Payables	16.32M					13.36M		5.28M			4.63M	4.93M	5.55M	5.54M
Payables	23.07M	4.54M	3.03M	3.37M	3.42M	17.08M		7.69M		2.35M	7.09M	7.63M	7.30M	7.98M	2.92M	1.14M	0.88M	1.33M	3.23M	1.12M
Accumulated Expenses						5.44M				5.47M	2.54M	3.72M	3.53M	4.07M	2.93M	5.04M	4.12M	2.03M	2.05M	2.46M
Other Accumulated Expenses						1.07M				1.02M	0.72M	3.44M	2.64M	1.10M	0.89M	0.78M	0.62M	0.74M	0.91M	1.07M
Short term Debt					19.35M
Current Taxes				2.05M
Total Current Liabilities	27.45M	11.67M	13.67M	16.93M	42.71M	29.75M		22.02M		9.49M	11.00M	15.47M	14.21M	13.85M	7.50M	7.56M	6.02M	4.30M	6.18M	5.68M
Non-Current Liabilities
Non-Current Debt	17.86M	22.00M	24.82M	19.42M				4.62M
Convertible Debt										4.39M
Operating Leases	13.75M	1.58M	2.70M	2.37M	1.77M	1.47M		1.23M		0.91M	0.73M	0.55M	0.39M	0.19M
Other Non-Current Liabilities	44.07M	69.21M	47.08M	11.25M	8.65M	0.86M		0.49M		1.21M	1.41M	1.52M	1.68M	1.45M	0.85M	1.01M	1.02M	0.73M	0.41M	0.46M
Total Non-Current Liabilities	77.77M	94.53M	75.25M	34.93M	3.94M	1.85M		6.86M		14.76M	11.69M	15.96M	159.60M	13.97M	7.39M	7.45M	5.99M	4.27M	6.15M	5.60M
Total Liabilities	105.30M	106.21M	88.92M	51.85M	46.65M	31.60M		28.88M		15.96M	13.10M	17.48M	161.28M	15.42M	8.24M	8.45M	7.00M	5.00M	6.56M	6.06M
Shareholder's Equity
Total Debt	34.17M	22.00M	24.82M	19.42M	19.35M	13.36M		9.90M			4.63M	4.93M	5.55M	5.54M
Common Equity		-20.41M	111.68M	118.79M	84.42M	74.59M	44.40M	49.67M	54.71M	50.54M	42.84M	78.65M	-72.54M	60.97M	60.08M	54.18M	46.60M	40.92M	34.05M	28.65M
Liabilities and Shareholders Equity	135.15M					77.41M				66.50M	55.94M	96.13M	88.75M	76.39M	68.32M	62.63M	53.60M	45.92M	40.61M	34.71M
Treasury Shares										0.92M
Retained Earnings	-333.22M	-422.13M	-411.97M	-400.86M	-383.52M	-399.26M		-431.67M		-419.63M	-428.60M	-440.84M	-455.84M	-462.88M	-472.03M	-486.64M	-493.70M	-501.02M	-507.54M	-514.54M

Mereo BioPharma Balance Sheet API

Pull Mereo BioPharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MREO&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "MREO", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=MREO&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Mereo BioPharma MREO Balance Sheet (2017-2026)

Mereo BioPharma Quarterly Balance Sheet

Mereo BioPharma Balance Sheet API

Create an account

Sign In

Reset Password